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Malignant mesothelioma is a major public   
health concern, because this rare form 
of cancer—caused specifically by expo-
sure to asbestos—is difficult to diagnose, 
has extremely poor prognosis, and is on the 
increase. Epidemics of mesothelioma have 
been reported nationally (Centers for Disease 
Control and Prevention 2009; Hodgson et al. 
2005; Kjellstrom and Smartt 2000; Murayama 
et al. 2006) and regionally (Pelucchi et al. 
2004; Peto et al. 1999), but available informa-
tion is biased toward developed countries and 
regions (referred to hereafter as “countries”) 
with the resources to diagnose asbestos-related 
diseases (ARDs) and with known historical use 
of asbestos. At present, mesothelioma is grossly 
under  reported in many developing countries 
(LaDou 2004; Takahashi and Karjalainen 
2003), including some with known extensive 
use of asbestos.
Few attempts have been made to quan-
tify the global incidence of mesothelioma. In 
a study of the total burden of occupational 
carcinogens, Driscoll et al. (2005) reported 
43,000 mesothelioma deaths/year, based on 
an estimated proportion of exposed workers 
and levels of exposure, combined with abso-
lute risk measures. This number, endorsed 
in a World Health Organization (WHO) 
document on the elimination of ARDs 
(WHO 2006a), is widely quoted to guide 
preventive activities. However, there has been 
no validation or reassessment of this 2005 
estimate, possibly because the indices that 
were used are difficult to access and repro-
duce. Commonly available statistics should 
be used to address the shortage of informa-
tion, which may also improve estimates of the 
  disease burden.
In a previous study (Lin et al. 2007), we 
calculated the volume of asbestos consumed 
per head (per-capita asbestos use) from a 
report by the U.S. Geological Survey (USGS) 
(Virta 2006) and used this value as a surro-
gate for population exposure level. Our results 
indicated that rates of past asbestos use can 
predict recent death rates from four types of 
ARDs at national levels and explained the 
bulk of the variance (Lin et al. 2007). This 
relationship, albeit ecological, is likely to 
reflect a causal relationship. Other researchers 
have used this surrogate indicator to estimate 
or predict ARDs in different populations 
(Antao et al. 2009; Tse et al. 2010).
Information related to mesothelioma 
frequency is accumulating in relation to the 
growing number of national and regional regis-
tries (Leigh and Driscoll 2003; Marinaccio 
et al. 2007). In the present study, we esti-
mated the magnitude of mesothelioma in the 
world accounting for both reported and unre-
ported numbers by using a global database 
and extending our previous ecological model. 
We incorporated updated data from the wid-
est possible sources of information, assum-
ing that mortality reflects incidence for this 
fatal form of cancer. We employed cumula-
tive indicators of asbestos use and number of 
mesothelioma cases, hypothesizing that recent 
national burden of mesothelioma is a conse-
quence of historical cumulative use of asbestos. 
This relation  ship was then applied to countries 
that lack rele  vant health data.
Materials and Methods
We extracted all data on asbestos use from a 
report by the USGS (Virta 2006, 2009). We 
adopted the USGS definition of use (produc-
tion plus import minus export), the data for 
which are available by country, in 10-year 
intervals from 1920 to 1970, in 5-year inter-
vals from 1970 to 1995, and annually from 
1995 to 2007. We treated a reported nega-
tive value of asbestos use (caused by storage, 
for example) as zero in this analysis. Using 
linear interpolation, cumulative asbestos use 
was calculated independently for two periods 
(1920–1970 and 1971–2007) to allow a suf-
ficient lag time from the earlier period to that 
of mesothelioma observation (1994–2008). 
When necessary, we interpolated values for 
asbestos use for the calendar year lacking data.
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Ba c k g r o u n d: Little is known about the global magnitude of mesothelioma. In particular, many 
developing countries, including some with extensive historical use of asbestos, do not report   
mesothelioma.
oBjectives: We estimated the global magnitude of mesothelioma accounting for reported and 
unreported cases.
Me t h o d s : For all countries with available data on mesothelioma frequency and asbestos use 
(n = 56), we calculated the 15-year cumulative number of mesotheliomas during 1994–2008 from 
data available for fewer years and assessed its relationship with levels of cumulative asbestos use dur-
ing 1920–1970. We used this relationship to predict the number of unreported mesotheliomas in 
countries for which no information on mesothelioma is available but which have recorded asbestos 
use (n = 33).
re s u l t s: Within the group of 56 countries with data on mesothelioma occurrence and asbestos 
use, the 15-year cumulative number of mesothelioma was approximately 174,300. There was a sta-
tistically significant positive linear relation between the log-transformed national cumulative meso-
thelioma numbers and the log-transformed cumulative asbestos use (adjusted R2 = 0.83, p < 0.0001). 
Extrapolated to the group of 33 countries without reported mesothelioma, a total of approximately 
38,900 (95% confidence interval, 36,700–41,100) mesothelioma cases were estimated to have 
occurred in the 15-year period (1994–2008).
co n c l u s i o n s: We estimate conservatively that, globally, one mesothelioma case has been over-
looked for every four to five reported cases. Because our estimation is based on asbestos use until 
1970, the many countries that increased asbestos use since then should anticipate a higher disease 
burden in the immediate decades ahead.
key w o r d s : asbestos, frequency, mesothelioma, mortality, prediction. Environ Health Perspect 
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The cumulative numbers of all types of 
mesothelioma [code C45; International 
Classification of Diseases, 10th Revision 
(ICD-10; WHO 2006b] were obtained 
from the WHO Mortality Database (WHO 
2010a) and tallied by country. Note that the 
WHO data comprise deaths registered in 
national civil registration systems, with under-
lying cause of death as coded by the relevant 
national authority (WHO 2010b). Data were 
extracted for countries with at least 3 years 
of data coded as C45 (ICD-10) or any of its 
subcategories. To maximize use of available 
data, we separately counted numbers recorded 
for malignant neoplasm of the pleura (code 
163; International Classification of Diseases, 9th 
Revision (ICD-9; WHO 1977)]. To investi-
gate countries that did not report data to the 
WHO, we used PubMed (National Center for 
Biotechnology Information 2010) and other 
sources to search for national frequency data 
published in English (Lee et al. 2010; Rüegger 
2008). Data were prioritized for analysis in 
that order, and overlapping information was 
evaluated once only. For a number of coun-
tries, national counts of mesothelioma deaths 
were reported for intermittent years or did not 
span the entire period. For each country, the 
15-year cumulative number was estimated by 
first calculating the annual mean of reported 
mesothelioma deaths from data available for 
fewer years, which was then multiplied by 15.
National population data were obtained 
from the WHO (2010a) and the U.S. Census 
Bureau (2010), and prioritized for use in 
that order.
Of the 89 analyzed countries, 12 warranted 
special treatment of asbestos use data because 
of political transition (e.g., disintegration, uni-
fication) or combined treatment with other 
countries/entities by the USGS. We used his-
torical information in an unbiased manner to 
the extent possible to give continuity with data 
of countries existing today:
•	Data	on	asbestos	use	for	the	Soviet	Union	
during 1920–1990 in the USGS database 
represented those of Russia and Kazakhstan 
combined (Virta 2006). We thus appor-
tioned data recorded by the Soviet Union 
during 1920–1990 between Russia and 
Kazakhstan during 1920–1990 according 
to the ratio of use recorded by Russia and 
Kazakhstan during 1995–2007.
•	Data	on	asbestos	use	for	West	and	East	
Germany during 1950–1985 were com-
bined into one entity (i.e., Germany).
•	To	account	for	the	disintegration	of	
Czechoslovakia in 1993 (United Nations 
2010), data on asbestos use for Czechoslovakia 
during 1920–1990 were apportioned to the 
level of use during 1995–2007 between Czech 
Republic and Slovakia.
•	To	account	for	the	disintegration	of	Yugoslavia	
in 1991 (Duffield 2003), data on asbestos use 
for Yugoslavia during 1930–1990 were appor-
tioned to the level of use during 1995–2007 
among Bosnia and Herzegovina, Croatia, 
Serbia and Montenegro, the former Yugoslav 
Republic of Macedonia, and Slovenia (we 
treated Serbia and Montenegro as one entity). 
•	Data	on	asbestos	use	for	Belgium	and	
Luxembourg were combined during 1930–
2001 in the USGS database (Virta 2006). 
We apportioned these data to Belgium and 
Luxembourg according to the size of the 
respective populations during this period.
We compiled all data and performed 
descriptive statistics using Microsoft Excel 
(Microsoft Corporation, Redmond, WA, 
USA). We then conducted the regression anal-
yses using SAS, version 9.1 (SAS Institute Inc., 
Cary, NC, USA). Because of the extremely 
wide dispersion of data for both asbestos and 
mesothelioma, data were log-transformed to 
construct the regression model: log10 (mortal-
ity) = B0 + [B1 × log10 (asbestos)], where B0 
is the intercept and B1 is the coefficient. We 
applied PROC REG (SAS Institute Inc.) to 
obtain the parameters and their confidence 
limits, the adjusted R2, and p-values of the 
regression model. The size of the national 
populations was used as weights. To further 
obtain the confidence limits for the mean pre-
dicted value for each observation, we added 
the confidence limits for the mean option. 
This accounted for the variation due to esti-
mating the parameters only. All the aforemen-
tioned processes were accomplished in one run 
of PROC REG.
After predicted values were obtained, 
based on the principle that if Yi ~ N(mi, si
2) 
is the measurement for the ith cluster then 
Y = sum(Yi) ~ N[sum(mi), sum(si
2)], the con-
fidence limits for the sum of predicted values 
were calculated from the square root of the 
sum of the variance.
We used Sigmaplot (version 9.01; Systat 
Software Inc., San Jose, CA, USA) to draw 
the figure; the size of the bubbles is propor-
tionate to the size of national populations of 
the year 2000. p-Values < 0.05 were deemed 
statistically significant in all analyses.
Results
Globally, 89 countries had available informa-
tion on frequency of mesothelioma and/or use 
of asbestos at the national level. These coun-
tries represented 82.6% of the global popu-
lation in the year 2000. Of these countries, 
56 had data for both mesothelioma frequency 
and asbestos use, and 33 had no mesothe-
lioma frequency data but had data for asbestos 
use (Table 1).
The cumulative asbestos use during 
1920–1970 was 51.2 million metric tons in 
the 56 countries having data on both meso-
thelioma frequency and asbestos use and 
14.2 million metric tons in the 33 countries 
having data on asbestos use only, totaling 
65.4 million metric tons in all 89 analyzed 
countries. This volume represented 100% of 
the global asbestos use during 1920–1970. By 
individual country, cumulative asbestos use 
was highly skewed, led by the United States, 
Russia, United Kingdom, Germany, and 
Japan, with volumes at 21.8, 8.4, 4.8, 4.1, and 
3.2 million metric tons, respectively (Tables 2 
and 3). The 56 countries with mesothelioma 
data reported a total of 92,133 deaths dur-
ing 1994–2008 (336 of which were coded as 
ICD-9 163 by four countries) (Table 1).
Table 2 shows the 15-year cumulative   
mortality of mesothelioma extrapolated 
from numbers reported for fewer years in the 
56 countries with mesothelioma data, ranked 
in order of the cumulative asbestos use. The 
15-year cumulative numbers are highly skewed 
but generally paralleled the level of cumula-
tive asbestos use. Leading countries for the 
15-year mesothelioma number are the United 
States (36,561 cases), the United Kingdom 
(28,369 cases), Italy (18,530 cases), Germany 
(15,948 cases), and France (12,390 cases) 
(Table 2). The total 15-year cumulative mor-
tality was approximately 174,300 deaths.
Figure 1 shows scatterplots of national 
data for the group of 56 countries. There is a 
clear positive linear relation between the log-
transformed values of the 15-year cumulative 
mortality of mesothelioma during 1994–2008 
and the cumulative use of asbestos during 
Table 1. Baseline characteristics of the 89 analyzed countries/entities with available data for asbestos 
and/or mesothelioma.
Data category
Both asbestos and  
mesothelioma (n = 56)
Asbestos only 
(n = 33)
Total 
(n = 89)
Asbestos, recorded cumulative use (million metric tons)
During 1920–1970 51.2 14.2 65.4
During 1971–2007 52.8 71.3 124.1
Mesothelioma, reported cumulative mortality during  
1994–2008 [No. of cases (no. of countries)]
ICD-10, code C45 90,929 (50) 0a (NA) NA
ICD-9, code 163 336 (4) 0a (NA) NA
Other data sourceb 868 (2) 0c (NA) NA
Total 92,133 (56) 0 (33) NA
NA, not applicable.
aNo record in WHO mortality database. bPublished articles in English identified via Pubmed or other source of national 
data (see References; Lee et al. 2010; Rüegger 2008). cData cannot be identified.Park et al.
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1920–1970. Cumulative asbestos use was a 
significant predictor of cumulative mesothe-
lioma mortality, with an adjusted R2 value 
of 0.83 (p < 0.0001). Similar findings were 
obtained when data for the four countries 
reporting deaths coded to the ICD-9 were 
omitted, with an adjusted R2 value of 0.82 
(p < 0.0001).
Table 3 shows the predicted 15-year cumu-
lative mortality of mesothelioma in the group 
of 33 countries that lacked data on mesothe-
lioma frequency; predictions were obtained 
from the value of cumulative asbestos use 
applied to the relationship obtained earlier. 
The range of cumulative asbestos use of the 
33 countries, except for Madagascar, fell within 
the range reported by the 56 countries. Leading 
countries for the predicted 15-year meso-
thelioma number are Russia (21,300 cases), 
Kazakhstan (6,500 cases), China (5,100 cases), 
India (2,200 cases), and Thailand (500 cases). 
In total, an estimated 38,900 [95% confidence 
interval (CI), 36,700–41,100] mesothelioma 
cases possibly occurred but were unreported 
during 1994–2008.
Discussion
It is unlikely that mesothelioma is absent in 
countries that have used asbestos but do not 
report mesothelioma frequency. There is 
increasing evidence that the extent of asbestos 
use can be used to predict subsequent incidence 
and mortality of ARDs at national levels (Antao 
et al. 2009; Lin et al. 2007; Nishikawa et al. 
2008; Tse et al. 2010). This is not unexpected, 
as mesothelioma is almost exclusively attribut-
able to past asbestos exposure. We thus postu-
lated that national experiences would follow 
reasonably similar patterns where countries lack-
ing mesothelioma data were probably “missing” 
the disease burden to an extent proportionate 
to the level of historical cumulative asbestos 
use. Based on available data of 56 countries, 
we observed that recent cumulative mortality 
of mesothelioma is closely related to historical 
cumulative use of asbestos. Further extrapola-
tion of this relation to the 33 countries with no 
available data for mesothelioma suggested that 
one mesothelioma case is unreported for every 
four to five cases reported worldwide (38,900 
unreported vs. 174,300 reported).
Accounting for the reported and unre-
ported numbers, we estimated the global bur-
den of mesothelioma to be 213,200 (15-year 
cumulative mortality during 1994–2008). 
This is equivalent to an annual average of 
approximately 14,200 cases, assuming a flat 
change rate, or approximately 25,000 cases in 
the year 2008 assuming a 10% annual increase 
rate (38,000 cases assuming a 20% annual 
increase rate). These estimates are larger than 
the estimated 10,000 mesothelioma deaths 
proposed by consensus for only the developed 
regions in the world (Tossavainen 1997) but 
smaller than the 43,000 mesothelioma deaths 
estimated for the world by Driscoll et al. 
(2005). Nevertheless, our values are reason-
ably close to those of earlier reports, despite 
the different methods used.
From the observed linear relation between 
log-transformed values of cumulative meso-
thelioma and asbestos, y = 10(0.913 * log x – 1.998),   
Table 2. Reported and extrapolated 15-year cumulative mortality of mesothelioma during 1994–2008 in 
56 countries/entities with data for mesothelioma mortality and use of asbestos.
Country (abbreviation) 
Cumulative use 
of asbestos, 
(tons),  
1920–1970
Years 
with 
available 
data (n)
Reported 
cumulative 
mortality 
(cases)
Annual average 
of reported 
mortality 
(cases)
Extrapolated 
15-year 
cumulative 
mortality (cases)
1 USA (USA) 21,840,583 7 17,062 2,437 36,561
2 UK (GBR) 4,829,517 7 13,239 1,891 28,369
3 Germany (DEU) 4,144,825 9 9,569 1,063 15,948
4 Japan (JPN) 3,210,349 14 11,212 801 12,013
5 France (FRA) 2,352,646 8 6,608 826 12,390
6 Canada (CAN) 1,955,347 5 1,603 321 4,809
7 Italy (ITA) 1,934,558 3 3,706 1,235 18,530
8 Australia (AUS) 1,152,776 8 3,747 468 7,026
9 Belgium (BEL) 1,110,214 3 467 156 2,335
10 Spain (ESP) 701,565 7 1,840 263 3,943
11 Poland (POL) 581,013 10 957 96 1,436
12 Brazil (BRA) 577,333 10 955 96 1,433
13 Romania (ROU) 550,799 10 581 58 872
14 Slovakia (SVK) 548,874 12 154 13 193
15 Denmark (DNK) 447,590 13 918 71 1,059
16 Mexico (MEX) 422,645 10 1,513 151 2,270
17 Sweden (SWE) 414,601 11 1,348 123 1,838
18 Netherlands (NLD) 411,989 13 5,141 395 5,932
19 Austria (AUT) 410,249 7 563 80 1,206
20 Argentina (ARG) 338,870 11 1,065 97 1,452
21 Finland (FIN) 299,695 13 970 75 1,119
22 Switzerland (CHE) 267,302 4 568 142 2,130
23 Republic of Korea (KOR) 244,802 12 339 28 424
24 Hungary (HUN) 235,442 13 451 35 520
25 South Africa (ZAF) 203,566 12 2,322 194 2,903
26 Colombia (COL) 196,345 9 323 36 538
27 Croatia (HRV) 165,011 14 547 39 586
28 Norway (NOR) 158,017 12 648 54 810
29 New Zealand (NZL) 147,197 7 513 73 1,099
30 Cyprus (CYP) 145,745 4 21 5 79
31 Czech Republic (CZE) 140,920 15 611 41 611
32 Egypt (EGY) 124,908 4 7 2 26
33 Chile (CHL) 103,780 9 331 37 552
34 Greece (GRC)a 101,021 15 128 9 128
35 Malaysia (MYS) 94,540 6 20 3 50
36 Slovenia (SVN) 94,114 12 270 23 338
37 Venezuela (VEN) 93,210 11 124 11 169
38 Portugal (PRT)a 90,605 8 152 19 285
39 Israel (ISR) 78,122 10 262 26 393
40 Taiwan (TWN) 67,670 12 300 25 375
41 Philippines (PHL) 41,132 5 51 10 153
42 Luxembourg (LUX) 38,749 9 39 4 65
43 Serbia and Montenegro 
(SRB & MNE)
34,222 12 313 26 391
44 Uruguay (URY) 33,914 6 38 6 95
45 Bulgaria (BGR) 33,576 4 35 9 131
46 Latvia (LVA) 22,189 13 112 9 129
47 Costa Rica (CRI) 11,718 9 24 3 40
48 Iceland (ISL) 6,417 12 28 2 35
49 Lithuania (LTU) 5,396 11 135 12 184
50 Guatemala (GTM)a 3,757 5 9 2 27
51 Panama (PAN) 3,506 7 14 2 30
52 Singapore (SGP)a 3,150 13 47 4 54
53 Estonia (EST) 2,300 12 45 4 56
54 Hong Kong (HKG) 616 7 79 11 169
55 Netherlands Antilles (ANT) 335 4 5 1 19
56 Nicaragua (NIC) 316 4 4 1 15
Total 51,229,638 NA 92,133 NA 174,300
NA, not applicable.
aNumber of cases represents malignant neoplasm of the pleura (ICD-9 code 163).Reported and unreported mesothelioma
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where y (cases) is the 15-year cumulative   
mesothelioma mortality for the period 
1994–2008, and x (metric tons) is the cumu-
lative asbestos use during 1920–1970. When 
values are back-transformed to their original 
units, there is a linear relation between variables 
x and y, each dispersed for a very wide range 
(i.e., to the power of 10). Further, the amount 
of asbestos use corresponding to one mesothe-
lioma case (asbestos-to-mesothelioma ratio), 
or x/y, varies depending on the level of x. For 
example, the asbestos-to-mesothelioma ratio is 
182–222 metric tons per case for cumulative 
use of 1,000–10,000 metric tons, and 271–331   
metric tons per case for cumulative use 
of 100,000–1,000,000 metric tons [see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.1002845)]. The values recorded here for 
the asbestos-to-mesothelioma ratio should 
be distinguished from a ratio reported by 
Tossavainen (2004) and referenced widely 
(fixed value of 170 metric tons per case); that 
value was derived using data from 11 devel-
oped countries with looser definitions and 
time frame.
The present study is the first to provide a 
global estimate of missed mesothelioma cases 
accounting for the experience of countries 
with data. We directly compared national 
asbestos use and mesothelioma frequency 
using cumulative indicators (the denominator 
population would be common to all calcula-
tions of rates); this method had the advantage 
of directly estimating the disease burden and 
maximizing use of sparse data. Asbestos has an 
extremely long industrial life span, and popu-
lations are repeatedly exposed during produc-
tion, maintenance, and abatement. Smoking 
is unrelated to mesothelioma and thus does 
not have to be accounted for as a confounder. 
These facts supported the assumption that 
cumulative asbestos use causes health effects 
that are reflected in the cumulative mesothe-
lioma count in populations.
There are, however, obvious limitations 
in the methods in the present study, as well 
as potential sources of errors in the informa-
tion applied. First and foremost, our find-
ings are based on an ecological relation, and 
thus we do not know the extent to which 
the consumed amounts of asbestos reflected 
actual exposure levels of populations. Second, 
extrapolating from the collective experience of 
one group of countries to another may intro-
duce bias, especially because the former group 
consisted of developed and developing coun-
tries, whereas the latter group consisted of 
predominantly developing countries. Third, 
we did not have information for consumed 
fiber types (e.g., amphiboles, chrysotile).
Whether and the extent to which the 
aforementioned limitations and possible errors 
collectively caused over  estimation or under-
estimation merits further consideration. One 
potential source of over  estimation (pertaining 
to the extrapolation of data from one group 
to another) is that developed countries may 
incur more mesothelioma cases because of an 
older age composition. However, this factor 
is probably offset by several potential sources 
of disease under  estimation: a) a lack of data 
on the trade of asbestos-containing products 
could impose additional risk; b) our estimates 
cannot account for the national experiences 
of the majority of countries in the world with 
no information on asbestos use (USGS infor-
mation on asbestos use may be less complete 
for the less-developed countries, especially 
for the earlier years); and c) under  diagnosis 
and under  reporting of mesothelioma is also 
a major problem in developed countries. 
Therefore, our values should be viewed as 
conservative estimates.
It is plausible that the hidden burden is 
substantial in countries with high cumula-
tive use of asbestos, including asbestos-pro-
ducing countries such as Russia, Kazakhstan, 
China, and India. Underdiagnosis and/or 
under  reporting may have occurred in these 
countries because of lack of awareness, knowl-
edge, and resources. It is also possible that, 
even if mesothelioma cases are diagnosed 
domestically, frequency numbers are not 
actively disclosed to the international com-
munity because of the increasing number 
of countries adopting bans on asbestos use 
(Kazan-Allen 2005) on grounds of public 
health. Some countries with vested interest 
in maintaining the production and trade of 
asbestos may be poorly motivated to acknowl-
edge ARDs. For example, Russia is known 
for not recognizing asbestosis in its territory 
(Walgate 2010).
The world nearly doubled cumulative use 
of asbestos from 65 million metric tons up 
until 1970, to 124 million metric tons since 
then. In particu  lar, the group of 33 countries 
not reporting mesothelioma frequency quin-
tupled asbestos use (Table 1). Individually, the 
number of countries exceeding the cumulative 
use of 3.0 million metric tons have increased 
from five in 1971 (United States, Russia, 
United Kingdom, Germany, and Japan) 
to eight: Russia (36.1 million metric tons), 
Table 3. Predicted 15-year cumulative mortality of mesothelioma in 33 countries/entities with data only 
for use of asbestos.
Country (abbreviation) 
Cumulative use of 
asbestos (tons), 
1920–1970
Predicted 15-year 
cumulative 
mortality (cases) 95% CI
1 Russia (RUS) 8,443,923 21,308 15,026–30,218
2 Kazakhstan (KAZ) 2,301,286 6,500 5,006–8,440
3 China (CHN) 1,767,086 5,107 3,976–6,558
4 India (IND) 688,015 2,158 1,700–2,739
5 Thailand (THA) 152,378 545 400–741
6 Zimbabwe (ZWE) 122,595 447 323–617
7 Algeria (DZA) 90,005 337 238–477
8 Swaziland (SWZ) 87,868 329 232–468
9 Iran (IRN) 68,437 262 181–380
10 Turkey (TUR) 60,345 234 159–343
11 Morocco (MAR) 55,697 217 147–321
12 Former Yugoslav Republic of Macedonia (MKD) 48,829 193 129–288
13 Lebanon (LBN) 47,718 189 126–283
14 Nigeria (NGA) 34,443 140 91–216
15 Peru (PER)a 32,645 133 86–207
16 Indonesia (IDN) 29,920 123 79–193
17 Democratic Republic of the Congo (COD) 22,579 95 59–153
18 Uganda (UGA) 18,139 78 47–128
19 Iraq (IRQ) 16,202 70 42–117
20 Zambia (ZMB) 15,607 68 41–113
21 Mozambique (MOZ) 14,566 64 38–107
22 Angola (AGO) 14,378 63 37–106
23 Jamaica (JAM) 10,698 48 28–83
24 Myanmar (MMR) 10,632 48 28–83
25 Tunisia (TUN) 9,724 44 25–77
26 Bolivia (BOL) 8,959 41 23–72
27 El Salvador (SLV)a 6,545 31 17–56
28 Kenya (KEN) 3,153 16 8–31
29 Botswana (BWA) 1,163 6 3–14
30 Senegal (SEN) 799 5 2–10
31 Libya (LBY) 540 3 1–7
32 Bosnia and Herzegovina (BIH) 387 2 1–6
33 Madagascar (MDG)b 16 NA NA
Total 14,185,272 38,900 36,700–41,100
NA, not applicable.
aTreated as lacking data on mesothelioma frequency because only 2 years of data were available in the WHO mortality data-
base and no other information could be identified (see “Materials and Methods”). bOut of range of the regression model.Park et al.
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China (11.2), Kazakhstan (9.6), Japan (8.1), 
the United States (6.9), Brazil (5.3), Germany 
(5.2), India (4.5), and Thailand (3.6) (data not 
shown). Thus, even with the expected hygienic 
improvements to reduce exposure over time, 
and particularly since 1970 onward, these 
countries should anticipate the need to deal 
with a very high burden of mesothelioma in 
the immediate decades ahead.
Developed countries should share expe-
rience and technology to enable developing 
countries to promote accurate diagnosis, report-
ing, and management of ARDs (Takahashi 
2008), including mesothelioma. Moreover, 
political will is essential to ensure that asbestos 
use ceases globally.
Conclusions
We estimated the 15-year cumulative fre-
quency of mesothelioma during 1994–2008 
in the 56 countries reporting mesothelioma to 
be 174,300. Using cumulative asbestos use to 
predict cumulative mesothelioma frequency 
at national levels, we predicted the 15-year 
cumulative frequency of mesothelioma dur-
ing 1994–2008 in the 33 countries that do 
not report mesothelioma to be 38,900 (95% 
CI, 36,700–41,100). Thus, globally, for every 
four to five reported cases of mesothelioma, 
one case has been over  looked. These estimates 
support the need for counter  measures at 
national, regional, and international levels. 
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Figure 1. Relationship between 15-year cumulative mortality of mesothelioma (1994–2008) and cumulative 
use of asbestos (1920–1970) weighted by the size of national populations in 56 countries/entities with data 
for both mesothelioma and asbestos use. Asbestos use for 33 countries/entities without mesothelioma 
frequency data is indicated along the x-axis. The figure is based on the following regression model: 
log10(15-year cumulative mortality of mesothelioma) = β0 + β1 × log10(cumulative use of asbestos), where 
β0 = –1.998 (95% CI, –2.676 to –1.319) and β1 = 0.913 (95% CI, 0.800 to 1.026). Adjusted R2 = 0.827; p < 0.0001.
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